Boston Medical Center (BMC) Grayken Center for Addiction Training and Technical Assistance (TTA)

A Resource for Healthcare and Social Services Professionals

Advancing Addiction Treatment: Building Knowledge of Substance Use and Specialty Topics

Strategies to Care for Persons Using Cannabis

Estimated time to complete: 30 minutes

This training will review the basics of cannabis use, health impacts, and harm reduction strategies. 


Register now

Description

This training will review the basics of cannabis use, health impacts, and harm reduction strategies. 

This training satisfies 0.50 hours of the required 8 hours of training for DEA-registered practitioners. The Medication Access and Training Expansion (MATE) Act was included in the Consolidated Appropriations Act, 2023. The MATE Act requires increased training for Drug Enforcement Administration (DEA)-registered physicians and practitioners—specifically, a one-time eight-hour training requirement on treating and managing patients with opioid or other substance use disorders.

Intended audience

Medical professionals with prescriptive authority, nurses and support staff who support them looking to increase provision of care for patients with substance use disorder.

Speakers

Other Faculty

Daniel P. Alford, MD, MPH, FACP, FASAM, CME Course Director, has no relevant financial relationships to disclose.

Colleen LaBelle, Planning Committee

Ilana Hardesty, MA, Planning Committee

Victoria Rust, BS, Planning Committee

Members of the planning committee have no relevant financial relationships to disclose.

Kristin Wason, MSN, NP-C, CARN (she/her)

Kristin is a clinical nurse educator for Boston Medical Center's Grayken Center for Addiction Training and Technical Assistance, an assistant professor of medicine at Boston University Chobanian & Avedisian School of Medicine, and a nurse practitioner at Boston Medical Center. Kristin contributes to peer-reviewed publications, evidence-based clinical guidelines, development and delivery of continuing education programs, and other resources for clinicians supporting patients with substance use disorders. Kristin is the Director of the Grayken Addiction Nurse Fellowship program, the first addiction nurse fellowship of its kind in the United States. She also sits on the BMC Substance Use Disorder Nursing Council. Kristin is an expert faculty member for the Provider Clinical Support System Exchange (PCSS-X) and co-chair of the Association for Multidisciplinary Education and Research in Substance Use and Addiction 2022 conference. Kristin's clinical interests include women's health, low-barrier treatment, and care of persons involved within the criminal-legal system. She is board-certified in addictions through the Addiction Nursing Certification Board. She earned her Master of Science in Nursing (MSN) from Salem State University and completed her undergraduate studies at the University of New Hampshire.

Kristin has no relevant financial relationships to disclose.

Objectives

Following this training, participants will have the knowledge necessary to:

Sponsored by

Boston Medical Center Grayken Center for Addiction Training and Technical Assistance, Massachusetts Department of Public Health, Bureau of Substance Addiction Services (DPH/BSAS)

Funding for out of state attendees is provided by the Opioid Response Network (ORN).

Funding for this initiative was made possible (in part) by grant no. 1H79TI081968 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.

Accreditation information

To earn credit, one must complete the pre-test, video, and pass the post-test evaluation. The evaluation closes two weeks after watching the video.

Continuing Medical Education (CME)

In support of improving patient care, Boston University Chobanian & Avedisian School of Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Boston University Chobanian & Avedisian School of Medicine designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Date of Release: 7/11/23

Date of Expiration: 7/11/24

Boston University Chobanian & Avedisian School of Medicine asks all individuals involved in the development and presentation of Accredited Continuing Education activities to disclose all financial relationships with ineligible companies. This information is disclosed to all activity participants prior to the start of the educational activity. Boston University Chobanian & Avedisian School of Medicine has procedures to mitigate all relevant financial relationships with ineligible companies. In addition, faculty members are asked to disclose when any unapproved use of pharmaceuticals and devices is being discussed. 

In accordance with the Standards for Integrity and Independence in Accredited Continuing Education, all relevant financial relationships that faculty, planners, authors, and anyone who may be in control of content have with ineligible companies have been mitigated.

Faculty members do not plan on discussing off-label/investigational uses of a commercial product.

THIS CONTINUING EDUCATION PROGRAM IS INTENDED SOLELY FOR EDUCATIONAL PURPOSES FOR QUALIFIED HEALTH CARE PROFESSIONALS. IN NO EVENT SHALL BOSTON UNIVERSITY BE LIABLE FOR ANY DECISION MADE OR ACTION TAKEN IN RELIANCE ON THE INFORMATION CONTAINED IN THE PROGRAM. IN NO EVENT SHOULD THE INFORMATION CONTAINED IN THE PROGRAM BE USED AS A SUBSTITUTE FOR PROFESSIONAL CARE. NO PHYSICIAN-PATIENT RELATIONSHIP IS BEING ESTABLISHED. IN NO EVENT SHOULD INFORMATION IN THE MATERIALS REGARDING LAWS, REGULATIONS, OR LEGAL LIABILITY BE CONSIDERED LEGAL ADVICE OR USED AS A SUBSTITUTE FOR CONSULTING WITH AN ATTORNEY.

Contact Hours for Nurses

Boston Medical Center is approved as a provider of nursing continuing professional development by the American Nurses Association Massachusetts, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation. Participants who complete the entire session, return the evaluation, and pass the post-test with a score of 70% will be awarded 0.50 contact hours, 0.25 of which are classified as pharmacology. 

This course expires on 7/14/2024

None of the planners or speakers have a financial relationship to disclose with ineligible companies. 

Register now

Grayken Center for Addiction TTA is a program of Boston Medical Center (BMC), a 514-bed academic medical center located in Boston's historic South End and the largest safety-net hospital in New England.

Funding for Grayken Center for Addiction TTA is provided by:

Massachusetts Department of Public Health Bureau of Substance Abuse Services (BSAS)
GE Foundation
Opioid Response Network

The content on this site and the content presented by Grayken Center for Addiction TTA is intended solely to inform and educate healthcare and social service professionals, and shall not be used for medical advice and is not a substitute for the advice or treatment of a qualified medical professional. The hospital, the program, and the contributors are not acting as health care providers or professional consultants on behalf of any specific patient and disclaim establishing a provider-patient relationship with any specific patient.


© 2024 Boston Medical Center. All rights reserved. Site by Root802.